These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15567151)

  • 1. 1.42A crystal structure of mini-IGF-1(2): an analysis of the disulfide isomerization property and receptor binding property of IGF-1 based on the three-dimensional structure.
    Yun CH; Tang YH; Feng YM; An XM; Chang WR; Liang DC
    Biochem Biophys Res Commun; 2005 Jan; 326(1):52-9. PubMed ID: 15567151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequences of B-chain/domain 1-10/1-9 of insulin and insulin-like growth factor 1 determine their different folding behavior.
    Chen Y; You Y; Jin R; Guo ZY; Feng YM
    Biochemistry; 2004 Jul; 43(28):9225-33. PubMed ID: 15248780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide exchange folding of disulfide mutants of insulin-like growth factor I in vitro.
    Hober S; Uhlén M; Nilsson B
    Biochemistry; 1997 Apr; 36(15):4616-22. PubMed ID: 9109671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sequence determinant causing different folding behaviors of insulin and insulin-like growth factor-1.
    Huang QL; Zhao J; Tang YH; Shao SQ; Xu GJ; Feng YM
    Biochemistry; 2007 Jan; 46(1):218-24. PubMed ID: 17198392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mini-proinsulin and mini-IGF-I: homologous protein sequences encoding non-homologous structures.
    Hua QX; Hu SQ; Jia W; Chu YC; Burke GT; Wang SH; Wang RY; Katsoyannis PG; Weiss MA
    J Mol Biol; 1998 Mar; 277(1):103-18. PubMed ID: 9514738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refolding of amphioxus insulin-like peptide: implications of a bifurcating evolution of the different folding behavior of insulin and insulin-like growth factor 1.
    Wang S; Guo ZY; Shen L; Zhang YJ; Feng YM
    Biochemistry; 2003 Aug; 42(32):9687-93. PubMed ID: 12911310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The different energetic state of the intra A-chain/domain disulfide of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
    Guo ZY; Shen L; Feng YM
    Biochemistry; 2002 Aug; 41(34):10585-92. PubMed ID: 12186542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the disulfide folding pathway of insulin-like growth factor-I.
    Milner SJ; Carver JA; Ballard FJ; Francis GL
    Biotechnol Bioeng; 1999 Mar; 62(6):693-703. PubMed ID: 9951525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change.
    Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC
    J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure determination of the three disulfide bond isomers of alpha-conotoxin GI: a model for the role of disulfide bonds in structural stability.
    Gehrmann J; Alewood PF; Craik DJ
    J Mol Biol; 1998 May; 278(2):401-15. PubMed ID: 9571060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The different folding behavior of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
    Guo ZY; Shen L; Feng YM
    Biochemistry; 2002 Feb; 41(5):1556-67. PubMed ID: 11814349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active-site disruption in native Limulus hemocyanin and its subunits by disulfide-bond reductants: a chemical probe for the study of structure-function relationships in the hemocyanins.
    Topham R; Tesh S; Cole G; Mercatante D; Westcott A; Bonaventura C
    Arch Biochem Biophys; 1998 Apr; 352(1):103-13. PubMed ID: 9521822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
    Sitar T; Popowicz GM; Siwanowicz I; Huber R; Holak TA
    Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13028-33. PubMed ID: 16924115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
    Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
    Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the regulation of insulin-like growth factors by IGF binding proteins.
    Siwanowicz I; Popowicz GM; Wisniewska M; Huber R; Kuenkele KP; Lang K; Engh RA; Holak TA
    Structure; 2005 Jan; 13(1):155-67. PubMed ID: 15642270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional solution structure of a disulfide bond isomer of the human insulin-like growth factor-I.
    Sato A; Koyama S; Yamada H; Suzuki S; Tamura K; Kobayashi M; Niwa M; Yasuda T; Kyogoku Y; Kobayashi Y
    J Pept Res; 2000 Oct; 56(4):218-30. PubMed ID: 11083061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entropic folding pathway of human epidermal growth factor explored by disulfide scrambling and amplified collective motion simulations.
    Zhang Z; Boyle PC; Lu BY; Chang JY; Wriggers W
    Biochemistry; 2006 Dec; 45(51):15269-78. PubMed ID: 17176049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs.
    Chandrashekaran IR; Yao S; Wang CC; Bansal PS; Alewood PF; Forbes BE; Wallace JC; Bach LA; Norton RS
    Biochemistry; 2007 Mar; 46(11):3065-74. PubMed ID: 17305365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into ligand-induced activation of the insulin receptor.
    Ward C; Lawrence M; Streltsov V; Garrett T; McKern N; Lou MZ; Lovrecz G; Adams T
    Acta Physiol (Oxf); 2008 Jan; 192(1):3-9. PubMed ID: 18171424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the insulin-IGF-I intermediate structures: functional and structural properties of the [TyrB25NMePheB26] insulin mutant.
    Záková L; Brynda J; Au-Alvarez O; Dodson EJ; Dodson GG; Whittingham JL; Brzozowski AM
    Biochemistry; 2004 Dec; 43(51):16293-300. PubMed ID: 15610023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.